A prostate biopsy is a procedure to remove small samples of tissue from the prostate gland. It's a method to test for prostate cancer if a prostate-specific antigen (PSA) blood test or digital rectal ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting the Decipher ® Prostate Biopsy genomic classifier (GC) may help guide treatment ...

PORTLAND, Ore. -- Biopsies detect prostate cancer in about one-fourth of men with abnormal screening tests. However, a negative biopsy does not ensure the absence of disease. Repeat prostate biopsies ...

A Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way that can also spare low-yield and potentially harmful procedures. Yale ...

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

Prostate cancer is the second most common form of cancer found in men worldwide, affecting one out of nine at some point in their lives. It’s also the second leading cause of cancer death among men in ...

A new blood test for prostate cancer that offers greater accuracy than prostate-specific antigen (PSA) has been put to the test by researchers at the University of East Anglia (UEA) in collaboration ...

IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST- July 31, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that MVZ Dr. Stein & Kollegen medical laboratory has signed an agreement to become the ...